PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 109 filers reported holding PMV PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $764,369 | -2.1% | 124,490 | -0.2% | 0.00% | – |
| Q2 2023 | $780,860 | +33.6% | 124,738 | +1.8% | 0.00% | – |
| Q1 2023 | $584,420 | -45.3% | 122,520 | -0.2% | 0.00% | – |
| Q4 2022 | $1,068,351 | -26.7% | 122,799 | +0.3% | 0.00% | – |
| Q3 2022 | $1,457,000 | -2.3% | 122,453 | +17.0% | 0.00% | – |
| Q2 2022 | $1,492,000 | -10.6% | 104,677 | +30.6% | 0.00% | – |
| Q1 2022 | $1,669,000 | -10.1% | 80,149 | -0.3% | 0.00% | – |
| Q4 2021 | $1,857,000 | -19.5% | 80,363 | +3.9% | 0.00% | – |
| Q3 2021 | $2,306,000 | +2.8% | 77,376 | +17.8% | 0.00% | – |
| Q2 2021 | $2,244,000 | +68.8% | 65,710 | +62.6% | 0.00% | – |
| Q1 2021 | $1,329,000 | -47.7% | 40,413 | -2.1% | 0.00% | -100.0% |
| Q4 2020 | $2,540,000 | – | 41,294 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $74,726,000 | 44.17% |
| Euclidean Capital LLC | 2,336,909 | $53,983,000 | 30.69% |
| OUP Management Co., LLC | 989,232 | $22,851,000 | 10.30% |
| Nextech Invest Ltd. | 1,385,807 | $32,012,000 | 8.43% |
| Boxer Capital, LLC | 2,838,236 | $65,563,000 | 2.55% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $12,713,000 | 2.38% |
| Orbimed Advisors | 7,330,423 | $169,333,000 | 2.18% |
| Asymmetry Capital Management, L.P. | 97,680 | $2,256,000 | 1.20% |
| RTW INVESTMENTS, LP | 2,980,960 | $68,860,000 | 1.01% |
| HighVista Strategies LLC | 39,777 | $919,000 | 0.73% |